
Reset all filters
01 1Taiho Oncology
02 4Taiho Pharmaceutical
Reset all filters
01 3Film Coated Tablet
02 2TABLET;ORAL
Reset all filters
01 1Approved
02 1Authorized
03 1Limited-Term
04 2RX
Reset all filters
01 2LYTGOBI
02 2Lytgobi
03 1Lytgoby
Reset all filters
01 1Spain
02 1Sweden
03 1Switzerland
04 2USA
Regulatory Info : Limited-Term
Registration Country : Switzerland
Brand Name : Lytgobi
Dosage Form : Film Coated Tablet
Dosage Strength : 4mg
Packaging :
Approval Date : 08/10/2024
Application Number : 69714
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : RX
Registration Country : USA
Brand Name : LYTGOBI
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2022-09-30
Application Number : 214801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYTGOBI
Dosage Form : TABLET;ORAL
Dosage Strength : 16MG
Packaging :
Approval Date : 2025-07-28
Application Number : 214801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lytgoby
Dosage Form : Film Coated Tablet
Dosage Strength : 4mg
Packaging :
Approval Date : 04/07/2023
Application Number : 20220504000014
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lytgobi
Dosage Form : Film Coated Tablet
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-09-21
Application Number : 1231741001
Regulatory Info : Authorized
Registration Country : Spain